Zeldana
- Manufacturer
- Misemer Pharmaceutical | Viva Pharmaceutical Inc
- Effective date
- 2021-12-14
- Label type
- Dietary Supplement
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:50:16
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Zeldana Label
HEALTH CLAIM SECTION
Zeldana is intended for the dietary management of a patient who, because of therapeutic or chronic medical needs, has limited or impaired chronic medical needs, has limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients, or who has other specific medically determined nutrient requirements, the dietary management of which cannot be achieved by the modification of a normal diet alone.
All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under physician's supervision. There are no implied or explicit claims on therapeutic equivilance
Manufactured for:
Misemer Pharmaceutical, Inc.
Ripley, MS 38663
Item 0708
Rev. 0821-1
DOSAGE & ADMINISTRATION SECTION
Usual adult dosage is one to two capsule daily or as directed by a licensed medical practitioner. Zeldana capsules are supplied as purple capsules printed with "354", dispensed in HDPE plastic bottles of 30ct.
PRECAUTIONS SECTION
Folic Acid, when administered as a single agent in doses above .1mg daily, may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. The .5 mg of cyanocobalamin contained in Zeldana has been shown to provide an adequate amount of cyanocobalamin to address this precaution. A safe upper limit of 100 mg per day has been established for the unsupervised medical use of pyridoxine. Consider all sources of pyridoxine supplementation when prescribing Zeldana.
If pregnant or planning to become pregnant or are currently breastfeeding, please contact your physician or health-care provider before using or continuing use.
ADVERSE REACTIONS
Allergic sensitization has been reported following both oral and parenteral administration of folic acid. Paresthesia and somnolence have been reported with pyridoxine HCl. Mild transient diarrhea, polycthemia vera, peripheral vascular thrombosis, itching transitory exanthema and feeling of swelling of entire body has been associated with cyanocobalamin.
DRUG INTERACTIONS
Pyridoxine supplements should not be given to patients receiving the drug levodopa, beause the action of levodopa is antagonized by pyidoxine. However, pyridoxine may be used concurrently in patients receiving a preparation containing both carbidopa and levodopa. Concurrent use of phenytoin and folacin (folic acid) may result in decreased phenytoin effectiveness.
PATIENT INFORMATION
Zeldana capsules are for use only under the direction and supervision of a licensed physician or health-care provider.
PREGNANCY and NURSING MOTHERS
Zeldana is not intended for use as a prenatal/postnatal multivitamin for lactating in non-lactating mothers. This product contains B Vitamins in active forms. Talk with your medical pratitioner before using if pregnant or lactating.
STATEMENT OF IDENTITY SECTION
Zeldana is an orally administered prescription supplement indicated for the distinct nutritional requirements of patients in need of dietary supplementation as determined by a licensed medical practitioner. Zeldana should be administered under the supervision of a licensed medical practitioner.
SAFE HANDLING WARNING SECTION
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient.
Store at controlled room temperature 15*-30*C (59*F-86*F). Keep in cool dry place. Call your doctor about side effects. You may report side effects to FDA at 1-800-FDA-1088. KEEP THIS OUT OF THE REACH OF CHILDREN.
Dispense by Prescription
WARNINGS SECTION
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Zeldana should only be used under the diretion and supervision of a licensed medical practioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications.
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cf050ccd-1144-f76a-e00d-e5698d8597d4 | Product name | 6 | 20250625 |
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| b82b4008-22fd-05f5-6cc6-c0a6e81c65b8 | Product name | 2 | 20240805 |
| baf7f49c-75b6-496b-a00e-8e766a8e4f03 | Product name | 1 | 20210127 |
| 91c62db0-0295-c81c-d10a-0856c259edd6 | Product name | 2 | 20200428 |
| d32bc2b8-0bb7-2216-87aa-24639646e202 | Product name | 3 | 20190619 |
| c5cd4727-ac49-4409-82b1-5bd8006c3ec7 | Product name | 1 | 20171122 |
| d206bb34-ea65-399d-70d9-834f22dc2c18 | Product name | 3 | 20170724 |
| 5e18e798-5614-cf5c-0185-38b1cb77a093 | Product name | 2 | 20160822 |
| ebc62596-fc97-4d03-9483-7ba095d25db7 | Product name | 1 | 20151210 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0276-0708-30 | Zeldana | 30 in 1 BOTTLE | CAPSULE | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0276-0708 | ZELDANA (FOLATE, CYANOCOBALAMIN, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, ASCORBIC ACID, PANTOTHENIC ACID) CAPSULE [MISEMER PHARMACEUTICAL] | 1 | 1 package rows | 20211216_b787a519-ae10-4538-b9bd-42fb0611d7b8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0276-0708-30 | EA - Each | 0276-0708 | c0daf919-8d62-4ab3-93f8-7226b44ccb38 | 1 | 2022-01-06 |
Products#
Every source-derived product name is available through these pages.
- Zeldana
- Folate, Cyanocobalamin, Thiamine hydrochloride, Riboflavin, Pyridoxine hydrochloride, Niacinamide, Ascorbic Acid, Pantothenic Acid
- FOLIC ACID
- CYANOCOBALAMIN
- THIAMINE HYDROCHLORIDE
- THIAMINE ION
- RIBOFLAVIN
- PYRIDOXINE HYDROCHLORIDE
- PYRIDOXINE
- NIACINAMIDE
- ASCORBIC ACID
- PANTOTHENIC ACID
- YELLOW WAX
- GELATIN TYPE B BOVINE (150 BLOOM)
- SOYBEAN OIL
- GLYCERIN
- WATER
- LECITHIN, SOYBEAN
- TITANIUM DIOXIDE
- FD&C BLUE NO. 1
- FD&C RED NO. 40
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0276-0708 | 0276-0708-30 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FOLIC ACID | 935E97BOY8 | ACTIB |
| CYANOCOBALAMIN | P6YC3EG204 | ACTIB |
| THIAMINE HYDROCHLORIDE | M572600E5P | ACTIB |
| RIBOFLAVIN | TLM2976OFR | ACTIB |
| PYRIDOXINE HYDROCHLORIDE | 68Y4CF58BV | ACTIB |
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| PANTOTHENIC ACID | 19F5HK2737 | ACTIB |
| YELLOW WAX | 2ZA36H0S2V | IACT |
| GELATIN TYPE B BOVINE (150 BLOOM) | F5AJW0ONK4 | IACT |
| SOYBEAN OIL | 241ATL177A | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
| LECITHIN, SOYBEAN | 1DI56QDM62 | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Folic Acid | FOLIC ACID | REMEDYREPACK INC. | bda4687e-929a-434d-ab59-909cf2ed73a2 | 2026-09-11 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Rising Pharma Holdings, Inc. | 0baa10dd-6d1d-4946-8236-566451132da3 | 2026-07-24 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Northwind Health Company, LLC | 03b0aee4-804a-de63-e063-6394a90a6635 | 2026-07-13 | Warnings, Adverse reactions | FOLIC ACID |
| FOLIC ACID | FOLIC ACID | Unit Dose Solutions, Inc. | 54db8b21-87b9-5e0c-e063-6394a90ae8ea | 2026-06-22 | Warnings, Adverse reactions | FOLIC ACID |
| Vitramyn | FOLIC ACID | PureTek Corporation | c8af7616-5178-6df0-e053-2a95a90a334d | 2026-06-18 | Warnings, Adverse reactions | FOLIC ACID |
| FOLIC ACID | FOLIC ACID | Coupler LLC | 544e394d-3555-8ab1-e063-6394a90ade00 | 2026-06-15 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Major Pharmaceuticals | 7778ac96-7817-455a-a177-22ecb276c67f | 2026-05-26 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | QUAGEN PHARMACEUTICALS LLC | 354366ea-3702-4706-9fc0-0244b7278bd8 | 2026-05-20 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Cardinal Health 107, LLC | 624469a1-ded9-453a-973e-c5a2f0602bb0 | 2026-05-15 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Cardinal Health 107, LLC | 6dd867fe-597e-4915-8baf-98a605bf9324 | 2026-05-06 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | a1b71c5d-c842-43fd-9557-2bb4e934b914 | 2026-04-23 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Preferred Pharmaceuticals Inc. | b4c3a754-64cd-499a-a32f-a6e935c41355 | 2026-04-22 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Amneal Pharmaceuticals of New York LLC | fd85395e-6a0b-4072-a80b-36095c0c6dd6 | 2026-04-15 | Warnings, Adverse reactions | FOLIC ACID |
| Multitam | FOLIC ACID | PureTek Corporation | cee15842-4a9e-c6ba-e053-2a95a90aebc5 | 2026-04-13 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | XGen Pharmaceuticals DJB, Inc. | c5b2b84d-9f5e-4b81-ba10-9f2854e5dce9 | 2026-01-21 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Aphena Pharma Solutions - Tennessee, LLC | 40ab3c91-5a5b-fa1d-e063-6394a90a7454 | 2025-12-10 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | American Health Packaging | fc6dc1e1-f63e-4239-a1eb-67525569f68c | 2025-11-13 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | 4889d474-bd72-46ba-81d6-5511d8a85abb | 2025-11-04 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | 41914ac8-f4f5-4d70-b9f2-9f88c59d67a6 | 2025-10-29 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | 1383dce2-0b81-4694-a662-27576f867eae | 2025-10-22 | Warnings, Adverse reactions | FOLIC ACID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
